About Anixa Biosciences (ANIX)
Anixa Biosciences, Inc. is a biotechnology company. The Company is developing a cancer immunotherapy program, which leverages chimeric endocrine receptor t-cell (CER-T) technology, and is engaged in developing a diagnostic platform called Cchek, for ... Read more
- USD4.63
- USD4.66
- USD4.29
- USD6.25
- 2.70%
- --
- 58.83k
- 66.18k
- 135M
- 2.50
- 63.30%
Stock News
1 hour ago
: Virgin Orbit stock plunges after report says company will cease operations
MarketWatch
1 hour ago
: Donald Trump reportedly indicted in Stormy Daniels case — first former U.S. president to ever be criminally charged
MarketWatch
1 hour ago
NY grand jury indicts Trump in hush money payment case
CNBC
1 hour ago
Earnings Results: Shares of right-wing social platform Rumble rally nearly 30% following Q4 results
MarketWatch
More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
